Signant Health Enhances Randomization and Trial Supply Management (RTSM) Platform
RTSM solution now offers additional benefits with the delivery of study supplies to patients' homes.
Signant Health has announced enhancements to its Randomization and Trial Supply Management (RTSM) platform to enable direct-to-patient clinical supply distribution.
The enhancements to Signant's RTSM solution enable secure and encrypted storage of patient shipment addresses, integration with depot/central pharmacy ordering systems, and courier status reporting.
Read more about the platform
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
Everything to Know About FDA’s Push Towards Radical Transparency in 2025September 17th 2025
IQVIA and Veeva Join Forces to Improve Efficiency and Patient OutcomesSeptember 17th 2025
Managing Background Therapies in the NIMBLE Phase III TrialSeptember 17th 2025
Generative AI Transforms Clinical Study Report DevelopmentSeptember 16th 2025
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
